Genmab A/S
NASDAQ:GMAB

Watchlist Manager
Genmab A/S Logo
Genmab A/S
NASDAQ:GMAB
Watchlist
Price: 22.63 USD -0.92% Market Closed
Market Cap: 14.4B USD

Wall Street
Price Targets

GMAB Price Targets Summary
Genmab A/S

Wall Street analysts forecast GMAB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GMAB is 120.41 USD with a low forecast of 15.4 USD and a high forecast of 272.86 USD.

Lowest
Price Target
15.4 USD
32% Downside
Average
Price Target
120.41 USD
432% Upside
Highest
Price Target
272.86 USD
1 106% Upside
Genmab A/S Competitors:
Price Targets
TLX
Telix Pharmaceuticals Ltd
35% Upside
VCYT
Veracyte Inc
51% Upside
ADCT
ADC Therapeutics SA
138% Upside
PRME
Prime Medicine Inc
390% Upside
INMB
INmune Bio Inc
195% Upside
TRDA
Entrada Therapeutics Inc
206% Upside
EDIT
Editas Medicine Inc
70% Upside
4974
Takara Bio Inc
59% Upside

Revenue
Forecast

Revenue Estimate
Genmab A/S

For the last 8 years the compound annual growth rate for Genmab A/S's revenue is 8%. The projected CAGR for the next 3 years is 117%.

8%
Past Growth
117%
Estimated Growth
Estimates Accuracy
1%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Genmab A/S

For the last 8 years the compound annual growth rate for Genmab A/S's operating income is 0%. The projected CAGR for the next 3 years is 121%.

0%
Past Growth
121%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

Net Income Estimate
Genmab A/S

For the last 8 years the compound annual growth rate for Genmab A/S's net income is 0%. The projected CAGR for the next 3 years is 104%.

0%
Past Growth
104%
Estimated Growth
Estimates Accuracy
-3%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GMAB's stock price target?
Price Target
120.41 USD

According to Wall Street analysts, the average 1-year price target for GMAB is 120.41 USD with a low forecast of 15.4 USD and a high forecast of 272.86 USD.

What is Genmab A/S's Revenue forecast?
Projected CAGR
117%

For the last 8 years the compound annual growth rate for Genmab A/S's revenue is 8%. The projected CAGR for the next 3 years is 117%.

What is Genmab A/S's Operating Income forecast?
Projected CAGR
121%

For the last 8 years the compound annual growth rate for Genmab A/S's operating income is 0%. The projected CAGR for the next 3 years is 121%.

What is Genmab A/S's Net Income forecast?
Projected CAGR
104%

For the last 8 years the compound annual growth rate for Genmab A/S's net income is 0%. The projected CAGR for the next 3 years is 104%.

Back to Top